From research to clinical manufacturing: optimizing iPSC therapies with reliable reagents
Complete the form below to download this White Paper & receive your promo code!
Stem cell therapy development requires consistent quality cytokines and growth factors throughout the transition from research to pre-clinical and clinical manufacturing. This case study explores the consistent performance of three grades of basic fibroblast growth factor and their effects on the morphology, pluripotency, genomic integrity and differentiation potential of induced pluripotent stem cells. Download the case study to discover how reagent consistency impacts therapeutic outcomes and learn best practices for ensuring reliable results.
On completion of the form you will receive the White Paper alongside your promo code.
Download now
This content was provided by Thermo Fisher Scientific.
